SKIN CANCER--IMMUNOTOXIC MECHANISMS
SKIN CANCER--IMMUNOTOXIC MECHANISMS
批准号:
3192700
负责人:
Craig A Elmets
金额:
$9.28万
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-06-01 至 1992-05-31
关键词:
benzopyrenes carbopolycyclic compound chemical carcinogen chemical carcinogenesis clone cells cutaneous papilloma cyclic compound cytochrome P450 delayed hypersensitivity disease /disorder model enzyme mechanism epoxides immune tolerance /unresponsiveness immunoregulation immunotoxicity laboratory mouse phorbols receptor skin hypersensitivity skin neoplasms toxin metabolism tumor promoters
中文摘要
点击翻译按钮获取中文摘要
英文摘要
There is an increasing awareness that the induction of skin cancer
is a multistep process requiring both initiating and promoting
substances for full development of the malignant tumor. Most
strategies examining immunological influences on this process have
focused on immune responses to tumors. This, however, represents
an investigation of such interactions at a rather late stage in the
pathway. The objective of this proposal will be to examine
immunological influences on skin carcinogenesis at an early stage
in the pathway. This will be accomplished by inducing a contact
dermatitis reaction in mice to two polyaromatic hydrocarbons, 7,12-
dimethylbenz(a)anthracene (DMBA) and benzo(a)pyrene (BP). These
compounds have been widely employed to investigate mechanisms of
skin cancer formation. Animals will be immunized to these agents
by epicutaneous application of the compound. Five days later the
response will be elicited by challenging their ears with the
sensitizing compound and measuring the subsequent ear swelling
response. Using this model system, participation of the Ah locus
in contact hypersensitivity responses both in strains of mice with
high an with low affinity Ah receptors. The role of cytochrome
P450 dependent enzyme metabolism in induction of contact
hypersensitivity to these agents will be assessed by pre-treating
animals with pharmacologic agents which induce or inhibit
cytochrome P450 activity. Also, various carcinogenic and non-
carcinogenic metabolites of BP and non-carcinogenic PAH analogues
will be tested for their immunogenicity by determining their
ability to initiate and elicit contact hypersensitivity responses.
Attempts will be made to induce immunological tolerance to DMBA and
BP by utilizing methods of tolerance induction which have been
successfully employed for other antigens. DMBA and BP-specific
T cell clones will be developed to more fully evaluate the
influence of antigen specific T lymphocytes on the tumorigenic
activity of these compounds. Finally, the influence of contact
immunization to DMBA and BP on the induction of tumors by these
agents will be examined in skin carcinogenesis experiments.
Knowledge obtained from these studies may help to define the
influence of cell-mediated immunity on skin carcinogenesis and may
offer new immunodermatologic approaches for the prevention and
therapy of this type of skin cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
UV Photodamage to the Skin: Prevention by Mutant p53 Immunization
-
批准号:10673138
-
项目类别:
-
资助金额:$18.56万
-
财政年份:2022
-
负责人:Craig A Elmets
-
依托单位:
UV Photodamage to the Skin: Prevention by Mutant p53 Immunization
-
批准号:10528677
-
项目类别:
-
资助金额:$22.28万
-
财政年份:2022
-
负责人:Craig A Elmets
-
依托单位:
RXR Rexinoids for Cancer Chemoprevention
-
批准号:10263919
-
项目类别:
-
资助金额:$90.04万
-
财政年份:2017
-
负责人:Craig A Elmets
-
依托单位:
RXR Rexinoids for Cancer Chemoprevention
-
批准号:10411342
-
项目类别:
-
资助金额:$5.99万
-
财政年份:2017
-
负责人:Craig A Elmets
-
依托单位:
Core 1: Administrative Core
-
批准号:10007602
-
项目类别:
-
资助金额:$11.42万
-
财政年份:2017
-
负责人:Craig A Elmets
-
依托单位:
Project 1: Evaluation of UAB30 on skin cancer biomarkers in human renal transplant recipients
-
批准号:10007598
-
项目类别:
-
资助金额:$37.6万
-
财政年份:2017
-
负责人:Craig A Elmets
-
依托单位:
Program Integration and Management
-
批准号:10263920
-
项目类别:
-
资助金额:$0.62万
-
财政年份:2017
-
负责人:Craig A Elmets
-
依托单位:
RXR Rexinoids for Cancer Chemoprevention
-
批准号:10007585
-
项目类别:
-
资助金额:$151.7万
-
财政年份:2017
-
负责人:Craig A Elmets
-
依托单位:
Project 1: Evaluation of UAB30 on skin cancer biomarkers in human renal transplant recipients
-
批准号:10263921
-
项目类别:
-
资助金额:$21.53万
-
财政年份:2017
-
负责人:Craig A Elmets
-
依托单位:
RXR Rexinoids for Cancer Chemoprevention
-
批准号:9761479
-
项目类别:
-
资助金额:$142.65万
-
财政年份:2017
-
负责人:Craig A Elmets
-
依托单位:
RXR Rexinoids for Cancer Chemoprevention
-
批准号:9904076
-
项目类别:
-
资助金额:$6.03万
-
财政年份:2017
-
负责人:Craig A Elmets
-
依托单位:
RXR Rexinoids for Cancer Chemoprevention
-
批准号:9554857
-
项目类别:
-
资助金额:$148.14万
-
财政年份:2017
-
负责人:Craig A Elmets
-
依托单位:
Core 1: Administrative Core
-
批准号:10263925
-
项目类别:
-
资助金额:$7.55万
-
财政年份:2017
-
负责人:Craig A Elmets
-
依托单位:
Topical Chemoprevention of Skin Cancer Biomarkers
-
批准号:10321199
-
项目类别:
-
资助金额:$22.98万
-
财政年份:2016
-
负责人:Craig A Elmets
-
依托单位:
Host Defense Mechanisms in Melanoma Pathogenesis
-
批准号:9290943
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Craig A Elmets
-
依托单位:
Topical Chemoprevention of Skin Cancer Biomarkers
-
批准号:9198928
-
项目类别:
-
资助金额:$33.63万
-
财政年份:2016
-
负责人:Craig A Elmets
-
依托单位:
Topical Chemoprevention of Skin Cancer Biomarkers
-
批准号:9960441
-
项目类别:
-
资助金额:$10.17万
-
财政年份:2016
-
负责人:Craig A Elmets
-
依托单位:
Host Defense Mechanisms in Melanoma Pathogenesis
-
批准号:9136376
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Craig A Elmets
-
依托单位:
Host Defense Mechanisms in Polyaromatic Hydrogen Carcinogenesis
-
批准号:8597412
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Craig A Elmets
-
依托单位:
Host Defense Mechanisms in Polyaromatic Hydrogen Carcinogenesis
-
批准号:8049280
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Craig A Elmets
-
依托单位: